The complement system and human autoimmune diseases.
Coss SL, Zhou D, Chua GT, Aziz RA, Hoffman RP, Wu YL, Ardoin SP, Atkinson JP, Yu CY.
J Autoimmun. 2023 May;137:102979. doi: 10.1016/j.jaut.2022.102979. Epub 2022 Dec 18.
Immunodeficiency: Complement disorders.
McMurray JC, Schornack BJ, Weskamp AL, Park KJ, Pollock JD, Day WG, Brockshus AT, Beakes DE, Schwartz DJ, Mikita CP, Pittman LM.
Allergy Asthma Proc. 2024 Sep 1;45(5):305-309. doi: 10.2500/aap.2024.45.240050.
Leukotriene C4 synthesis deficiency: a member of a probably underdiagnosed new group of neurometabolic diseases.
Mayatepek E.
Eur J Pediatr. 2000 Nov;159(11):811-8. doi: 10.1007/s004310000601.
[C4 deficiency].
Ohno T.
Ryoikibetsu Shokogun Shirizu. 2000;(32):199-202.
Partial C4 deficiency in juvenile idiopathic arthritis patients.
Gilliam BE, Wolff AE, Moore TL.
J Clin Rheumatol. 2007 Oct;13(5):256-60. doi: 10.1097/RHU.0b013e318156b9e3.
Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes.
Veremeyko T, Jiang R, He M, Ponomarev ED.
Front Cell Neurosci. 2023 May 10;17:1170031. doi: 10.3389/fncel.2023.1170031. eCollection 2023.
Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.
Boteva L, Morris DL, Cortés-Hernández J, Martin J, Vyse TJ, Fernando MM.
Am J Hum Genet. 2012 Mar 9;90(3):445-56. doi: 10.1016/j.ajhg.2012.01.012. Epub 2012 Mar 1.
A complement C4-derived glycopeptide is a biomarker for PMM2-CDG.
Garapati K, Budhraja R, Saraswat M, Kim J, Joshi N, Sachdeva GS, Jain A, Ligezka AN, Radenkovic S, Ramarajan MG, Udainiya S, Raymond K, He M, Lam C, Larson A, Edmondson AC, Sarafoglou K, Larson NB, Freeze HH, Schultz MJ, Kozicz T, Morava E, Pandey A.
JCI Insight. 2024 Apr 8;9(7):e172509. doi: 10.1172/jci.insight.172509.
Involvement of C4 allotypes in the pathogenesis of human diseases.
Samano ES, Ribeiro Lde M, Gorescu RG, Rocha KC, Grumach AS.
Rev Hosp Clin Fac Med Sao Paulo. 2004 Jun;59(3):138-44. doi: 10.1590/s0041-87812004000300009. Epub 2004 Jul 28.
Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.
Kotilainen H, Lokki ML, Paakkanen R, Seppänen M, Tukiainen P, Meri S, Poussa T, Eskola J, Valtonen V, Järvinen A.
PLoS One. 2014 Mar 17;9(3):e91450. doi: 10.1371/journal.pone.0091450. eCollection 2014.
